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ABSTRACT
The CCAAT box is a frequent promoter element, as
illustrated by bioinformatic analysis, and it is bound
by NF-Y, a trimer with H2A-H2B-like subunits.
We developed a MNase I-based ChIP protocol on
homogeneous cell populations to study cell-cycle
promoters at the single nucleosome level. We ana-
lyzed histone methylations and the association of
enzymatic activities. Two novel results emerged:
(i) H3-H4 are present on core promoters under
active conditions, with the expected cohort of ‘posi-
tive’ modifications; H2A-H2B are removed and sub-
stituted by NF-Y. Through the use of a dominant
negative mutant we show that NF-Y is important
for H3K36me3 deposition and for elongation, not
recruitment of Pol II; (ii) H3K4 methylations are
highly dynamic and H3K4me1 is a crucial positive
mark. Functional siRNA inactivation and treatment
with Tranylcypromine determined that KDM1 (LSD1)
plays a positive role in transcription, specifically of
G2/M genes. It requires CoREST, which is recruited
on active promoters through direct interactions with
NF-Y. These data are the first in vivo indication
of a crucial interplay between core histones and
‘deviant’ histone-fold such as NF-Y, leading to
fine-tuning of histone methylations.
INTRODUCTION
The fundamental unit of chromatin is the nucleosome,
formed by 146bp of DNA wrapped around four hetero-
dimers of H2A-H2B and H3-H4 core histones (1).
Histones are among the most conserved proteins in
eukaryotes; they are formed by N- and C-terminal tails
and a globular part, the histone-fold domain. The histone
tails have long been known to be modiﬁed by a plethora
of post-translational modiﬁcations—PTMs—and it is now
clear that these are marks of peculiar chromatin
environments (2–6). Some of them are associated with
accessible, active chromatin, others with heterochromatin,
either constitutive or facultative.
An enormous amount of information has been gathered
on histone PTMs, thank to ﬁne proteomic analysis and the
development of antibodies highly speciﬁc for single mod-
iﬁcations. Acetylations of H3 and H4, in particular, are
believed to be hallmark of active areas of genomes.
Methylation of lysines, instead, represents complex signals
for two reasons: the ﬁrst is that some residues are asso-
ciated with ‘open’ or transcribed chromatin—H3K4,
H3K36 and H3K79—while others—H3K9, H3K27 and
H4K20—are signposts of repression. The second refers
to the fact that single, double or triple methylations can
be imposed on lysines and that these are often marks of
diﬀerent chromatin states. The presence of histone PTMs
posits that they are the result of speciﬁc enzymatic activ-
ities, and that they are read by proteins, or complexes, that
further modify histones and impact on aspects of DNA
metabolism in general, and on transcription in particular.
The complexity of the histone PTMs has been recently
highlighted by genome-wide analysis, in which new
concepts have emerged (7–15). Not only acetylations,
but also methylations are dynamic, and a plethora of
demethylases—KDMs—with restricted range of speciﬁ-
city emerged. KDM1 (LSD1) is speciﬁc for H3K4me2
and H3K9me2 (16, reviewed in ref. 17), whereas
KDM5A, KDM5B and KDM5C/D preferentially
demethylate H3K4me2/3 (18–21, reviewed in ref. 22).
The majority of histones PTMs analyzed so far are
within the tails, but others are within the histone-fold
(23); methylations and acetylations are found on lysines
that are predicted to contact DNA directly in the nucleo-
somal structure, or that are involved in contacts between
the H3-H4 tetramer and the H2B-H2A dimers.
Core histones share the histone-fold domain not only
with ‘variant’ histones, such as H2A.Z and H3.3, which
show limited aminoacids variations, but also with more
distantly related proteins, whose structures have been
detailed by crystallographic studies (24–27). Despite
a relatively low level of primary sequence identity,
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served. One such factor is NF-Y, a trimeric complex
whose NF-YB-NF-YC subunits resemble H2B-H2A,
respectively (28). The heterodimer oﬀers several docking
spots for NF-YA association and the resulting trimer
contacts DNA through a complex set of sequence-
speciﬁc interactions—mainly via NF-YA—as well as non-
sequence-speciﬁc contacts, through the L1-L2 loops of
NF-YB-NF-YC (29 and references therein). Evolu-
tionarily conserved lysines and arginines of H2B-H2A
that make important DNA-binding contacts within the
nucleosome are often conserved in NF-YB-NF-YC, and
required for DNA binding. The sequence recognized by
NF-Y is the CCAAT box, known to be an element fre-
quently present in promoters and enhancers (30–33). It is
essential for early mouse development (34) and, in accor-
dance with its ubiquitous expression, it has a wide range of
targets: cell-cycle genes, and those speciﬁcally active in the
G2/M phase, stand out for having a distinctly higher fre-
quency of CCAAT boxes (35). A prominent role of NF-Y
in the G2/M transition has been recently conﬁrmed by
proﬁling experiments of cells RNAi-inactivated for the
NF-YB subunit, or infected with a Dominant Negative
NF-YA (36,37). Intriguingly, while NF-Y was once con-
sidered a hallmark of activation, ChIP on chip data indi-
cate a link to repressed areas, associated to H4K20me3 and
H3K27me3 (38). Cause–eﬀect experiments indicated that
the presence of H3K4me3 and H3K79me2 is linked to
NF-Y binding to active promoters (39).
A limitation to the analysis of histone PTMs is imposed
by the scarcely precise nature of ChIP procedures derived
from sonication of chromatin: it is essentially impossible to
pinpoint precisely modiﬁcations on a single nucleosome,
as well as discriminate areas that are devoid of nucleo-
somes. To obviate this, several studies have used micrococ-
cal nuclease I, which cuts chromatin in the linker region
between nucleosomes. Nucleosome-free regions—NFRs—
have emerged around the transcription start site—TSS—at
the single-gene level and, more recently, in genome-wide
studies (40–44). This type of analysis has been predomi-
nantly coupled to ChIP with antibodies against histones
and their PTMs; transcription factors and enzymatic
complexes that are indirectly associated with DNA are
less studied by these approaches (45), possibly because of
concerns about the recovery of MNase I-cut DNA in
nucleosome-free areas.
We used a MNase I-derived ChIP assay in relatively
homogeneous cell populations to study binding of NF-Y
and histones, their PTMs and modifying machines. We
derived maps of single nucleosomes on two cell-cycle regu-
lated genes: Cyclin B2 and PCNA. Not only was this pro-
cedure accurate, but it was also very sensitive and suitable
both for transcription factors—TFs—and proteins modi-
fying histones PTMs.
MATERIALS AND METHODS
Cell cultures,chemicals and pharmacological treatment
HCT116 p53
–/– cells were cultured in McCOY’S
medium supplemented with 10% FCS, 1% penicillin
and streptomycin and L-glutamine. Stock solutions
of nocodazole (Sigma M1404), tranylcypromine
(tranylcypromine-2-phenylcyclopropylamine, Sigma
P8511) were prepared in DMSO at a concentration of
10mg/ml and 50mg/ml, respectively. Cells at 60–70%
conﬂuence were treated for 16 hs with 1.2mM nocodazole
and 2mM tranylcypromine; after nocodazole treatment,
cells were washed twice with PBS and released from the
block with fresh medium for 8h.
All transfections were carried out using Lipofectamine
2000 (Invitrogen, USA), following the manufacturer’s
instructions. The sequence of the KDM1 siRNA was
50-UUUCCAUGAUACCAGCAGCUU(dTdT)-30 and
of coREST 50-AAGAUUGUCCCGUUCUUGACU
(dTdT)-30. Scrambled DNA was used as a negative control
(Ambion USA). Infections with Ad-YAm29, Ad-YAwt
and Ad-GFP adenoviruses were carried out as described
previously (46).
RNA,protein and immunoprecipitation analysis
For FACS analysis, cells were harvested, washed three
times with cold PBS, ﬁxed with EtOh 95%, kept on ice
for 30min, RNAse treated (1mg/ml) for 30min; ﬁnally, a
propidium iodide solution (P4864, 1mg/ml) was added for
30min on ice and in the dark; Becton Dickinson FACScan
was used for analysis. Total RNAs were extracted using
an RNA-Easy kit (Qiagen, Germany). One microgram of
each RNA was retrotranscribed using SuperScript II and
Random primers (Invitrogen, USA). Quantitative real-
time PCRs were performed, normalizing all cDNAs for
the GAPDH control. The RT-PCR primers are reported
in Supplementary Figure 3.
Nuclear extracts were prepared collecting cells in Buﬀer
A (10mM HEPES, pH 7.9, 10mM KCl. 0.1mM EDTA,
0.1mM EGTA, 1mM DTT, protease inhibitors cocktail,
1mM PMSF) for 30min on ice; NP-40 was added to a
ﬁnal concentration of 0.625%, cells vortexed for 10s and
centrifuged at 13000 r.p.m. for 1min. Pelletted nuclei
were resuspended in ice-cold buﬀer C (20mM HEPES,
pH 7.9, 0.42M NaCl, 0.1mM EDTA, 0.1mM EGTA,
1mM DTT, protease inhibitors cocktail, 1mM PMSF),
rocked at 48C for 30min and centrifuged at 13000
r.p.m. for 5min. Supernatants were quick-frozen and
stocked at –808C. For western blotting, 30mg of nuclear
extracts were used in 12% SDS–PAGE gels, proteins
transferred to nitrocellulose membrane (Protran,
Whatman), decorated with the antibodies of interest and
detected using horseradish peroxidase-conjugated second-
ary antibodies (GE Healthcare UK) and the SuperSignal
enhanced chemioluminescence system (Pierce, USA).
For immunprecipitations, 1mg of nuclear extract
were precleared with protein G-Sepharose (50ml) with
10  volume of RIPA buﬀer (50mM Tris–Cl, pH 7.4,
150mM NaCl, 1% NP-40, 0.25% Na-deoxycholate,
1mM PMSF). Protein G-Sepharose was added to the cell
lysate with the primary antibody (30mg of anti-NF-YB or
anti-thioredoxin) and incubated for 3h at 48C. After incu-
bation, centrifuged for 1min and the pellet washed in
1.5ml of RIPA buﬀer. The immunoprecipitated material
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and loaded on an SDS gel for western blot analysis.
Chromatin immunoprecipitation
A measure of 10
7 exponentially growing HCT116 p53
–/–
cells were washed with PBS and incubated for 10 mins
with 1% formaldehyde; after quenching the reaction
with Glycine 0.125M, cells were harvested and pelletted.
Pellets were resuspended in 2ml lysis buﬀer (0.1M PIPES
pH8, 1M KCl, 10% NP-40), kept on ice for 30min and
dounced 10 times (Type B Pestle). Nuclei were pelletted
at 10min at 48C, resuspended in 2ml of sonication buﬀer
without EDTA (50mM Tris–HCl, pH 8, 0.1% SDS,
0.5% deoxycholic acid) and brieﬂy sonicated (three to
ﬁve pulses). CaCl2 and MgCl2 were added to a ﬁnal con-
centration of 5mM; digestion was performed with 10–20
U of micrococcal nuclease (MNase I, Worthington) at RT
for 10–15min, stopped by placing the reaction at 48C
and adding EDTA to a ﬁnal concentration of 20mM.
The digestion was controlled by reversing crosslinking of
a small amount of chromatin, incubating at 658C o/n
with RNase A (10mg/ml), then at 508C for 3h with
Proteinase K; ﬁnally, the DNA was phenol–chloroform
extracted, ethanol precipitated and run on a 2%
agarose gel.
ChIP assays were performed as previously described
(39) with 3mg of the following antibodies: NF-YB
(Diagenode, Belgium); unmodiﬁed H2B (Abcam 1790);
unmodiﬁed H3 (Abcam 1791); unmodiﬁed H4 (Abcam
7311); H3K4me1 (Abcam 8895); H3K4me2
(Abcam 7766); H3K4me3 (Abcam 8580); H3K79me2
(Abcam 3594); H3K36me3 (Abcam 9050); H3K27me3
(Upstate 07-449); H4K20me3 (Abcam 9053), Pol II
(Covance); KDM1 (pAB-028-050, Diagenode); coREST
(Abcam 24166); KDM5A (Abcam 45301); KDM5B
(Abcam 50958); Menin (BL342 Bethyl, USA);
KTM5B (Abcam 49251); Flag control antibody (Sigma).
The ChIP-PCR primers used for these experiments are
reported in Supplementary Figure 3.
Real-timePCR
Quantitative real-time PCR was performed using SYBR
green IQ reagent (Biorad, USA) in the iCycler IQ detec-
tion system. Primers were designed to amplify genomic
regions of 120–140bp in size. The relative sample
enrichment was calculated with the following formula:
2
Ctx 2
Ctb, where Ctx¼Ct input Ct sample and
Ctb¼Ct input Ct control Ab.
RESULTS
Mapping ofnucleosomes and NF-Ybinding on two
cell-cycle regulated promoters
To develop a system in which PTMs of single nucleosomes
could be analyzed, we introduced two modiﬁcations in the
ChIP procedure: (i) we used HCT116 cells syncronized
in G2/M by nocodazole treatment, (FACS analysis
in Figure 1A). Cells were then released and cell-cycle
progression monitored at diﬀerent time points (data not
shown): after 8h, we found that a maximum of cells were
at the G1/S boundary (Figure 1A). RT-PCR analysis of
cell-cycle genes conﬁrmed the upregulation of Cyclin B1
and Cyclin B2 in G2/M-arrested cells, downregulation of
the G1 gene Cyclin D1, and of the G1/S E2F1, PCNA and
TK1 (Figure 1B). Conversely, these latter genes were
re-activated after the release, and Cyclin B1 and Cyclin
B2 repressed. Internal controls—GAPDH, NF-YA and
NF-YB—showed little variation in the conditions consid-
ered; (ii) chromatin was prepared with MNase I treatment,
rather than sonication. Figure 1C shows the diﬀerence in
the two protocols, with sonicated material having an aver-
age length of 1.3kb and careful titration of MNase I-redu-
cing chromatin to single nucleosomes. Binding of NF-Y to
two representative CCAAT promoters—PCNA and
Cyclin B2—was monitored in cycling, G1/S and G2/M
cells by ChIP analysis with two sets of core promoter
primers. Figure 1D shows that NF-Y is bound to both
promoters in cycling cells, but only to PCNA in G1/S
cells, and to Cyclin B2 in G2/M. This is in agreement
with previous work on mouse NIH3T3 cells (47). In addi-
tion, we compared the eﬃciency of NF-Y recovery in G1/
S and G2/M in ChIPs perfomed with sonicated and
MNase I-treated chromatins. The 10-fold enrichment
with anti-NF-YB over a control FLAG antibody routi-
nely scored with sonicated material was dramatically
enhanced to 80/90-fold in MNase I ChIPs. Overall, these
data establish a sensitive, MNase I-based ChIP
procedure based on relatively homogeneous populations
of synchronized cells.
The MNase I chromatin was used in ChIP experiments
with anti-NF-YB, H2B and H3 antibodies, to establish
the position of single nucleosomes within the Cyclin B2
and PCNA promoters. To assay this, we performed
analysis with a large set of amplicons of 140–160bp,
with primers placed at a distance of 20bp across the
 500/þ500 region (Supplementary Figure 1). Representa-
tive results of this analysis are shown in Figure 2A: with
primers located within a single nucleosome, or in the core
promoters, amplicons are positive in semiquantitative
PCRs with inputs DNA, as well as with the indicated
antibodies, depending on the locations. On the other
hand, when we used primers positioned across distinct
nucleosomes, hence encompassing two nucleosomes, dis-
crete fragments, either from inputs, or from ChIPped
material, were more diﬃcult to amplify, even at high
PCR cycles. The same results were obtained with quanti-
tative real-time PCR analysis (see below). Note that with
MNase I-treated chromatin derived from cycling cells,
positioning of nucleosomes could not be determined by
this method, most likely because of the presence of cell
populations in diﬀerent phases of the cell cycle (data
not shown).
In Figure 2A, analysis of ChIPs indicate that NF-Y is
bound to core promoters, PCNA in G1/S cells (upper
panel) and Cyclin B2 in G2/M cells (lower panels); it is
largely absent in amplicons detecting neighboring nucleo-
somes. H2B was speciﬁcally evicted from core promoter
areas, but easily recoverable in upstream and downstream
nucleosomes. Residual binding of NF-Y and H2B was
most likely due to the incomplete homogeneity of the
6594 Nucleic Acids Research, 2008, Vol. 36, No. 20cellular populations. The H3 data were constant across the
diﬀerent areas, including in the core promoter. Q-PCR
analysis in diﬀerent cell-cycle conditions are shown in
Figure 2B. We conclude that the use of MNase I chroma-
tin allows us to map with a reasonable degree of precision
nucleosomes positioning on the PCNA and Cyclin B2
promoters in vivo, that H2B, but not H3, is evicted from
core promoters, and replaced by NF-Y under active
conditions.
Analysisof histonemodifications during thecell cycle
The system outlined above was used to evaluate the levels
of histone methylations, as assessed with commercially
available antibodies. Note that these reagents were used
according to the speciﬁcities described by the vendors, and
not tested by us in other assays. The results are shown in
Figure 3. H3K36me3 and H3K79me2, which are asso-
ciated with high levels of gene expression, were high
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Figure 1. Development of single nucleosome ChIP assays in synchronized human cells. (A) Flow cytometry histograms of HCT116 cells untreated
and treated with nocodazole for 16h. The chart shows the percentages of cells in the diﬀerent phases of the cell cycle: cycling, nocodazole-treated
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Nucleic Acids Research, 2008, Vol. 36, No. 20 6595across active promoters, and very low in inactive promot-
ers. H3K4me3 also correlated with expression, as
expected, but was distinctly higher than background on
inactive promoters. The pattern of H3K4me1 was similar,
except that positivity on inactive conditions was residual:
indeed this mark best correlated with expression. Interest-
ingly, H3K4me2 was much less polarized toward expres-
sion, and, in fact, more abundant on inactive promoters.
As for methylations associated to repressed conditions,
H3K27me3 was marginally enriched and quite ﬂat in the
diﬀerent conditions, while H4K20me3 was increased
under inactive conditions and dropped during activation,
both on PCNA and Cyclin B2, speciﬁcally downstream of
the TSS. All these marks were normalized for the levels
of histones H3 and H4 analyzed in parallel. The positivity
of histone H3 methylations on core promoters further
indicate that H3 is indeed associated to active promoters,
and pinpoint a precise switch in H3K4 methylations
during the cell cycle.
Recruitment of histone-modifying enzymes on cell-cycle
promoters
Next, we assayed proteins known to impact on the PTMs
analyzed above, such as Menin, a component of the
KMT2 (MLL) complex, which is responsible for deposi-
tion of the H3K4me marks (48): it was indeed present
under active conditions, in keeping with the H3K4me1
and H3K4me3 levels (Figure 4A). Both on Cyclin
B2 and PCNA, the levels were maximal on the –2 nucleo-
some and minimal on the core promoter. We examined the
binding of histone demethylases, KDMs. KDM1 (LSD1)
works with CoREST, a nucleosome-binding factor,
to remove methyl-groups from H3K4me2/me1, but not
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Figure 2. Single nucleosome mapping on Cyclin B2 and PCNA promoters. (A) Semiquantitative PCR analysis of ChIPs with G2/M and G1/S cells;
representative amplicons indicate nucleosomes positioning, according to the strategy detailed in Supplementary Figure 1. The antibodies used are
indicated. (B) Distribution of core histone proteins and NF-Y on the Cyclin B2 and PCNA promoters, from –500bp toþ500bp. The black bars
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6596 Nucleic Acids Research, 2008, Vol. 36, No. 20H3K4me3 (16,49,50); KDM5A (RBP2) and KDM5B
(PLU-1) contain a JmjC domain, able to demethylate
H3K4me3/2 to the unmodiﬁed state (22). Figure 4A
shows the distribution of these enzymes: when the two
genes are transcribed, KDM1 and KDM5A are bound
in a relatively broad way, decreasing in repressive condi-
tions. Similarly, CoREST is recruited only on active pro-
moters. KDM5B behaved diﬀerently, as the distribution
was somewhat less modiﬁed by cell-cycle conditions.
To verify whether this pattern was speciﬁc for these
promoters, we analyzed other cell-cycle promoters active
in G1 and S—Cyclin D1, E2F1 and Cyclin A—and
the results were very similar, namely association of
KDM1 and KDM5A under active conditions and of
KDM5B independently from the phase of the cell cycle
(Figure 4B). KDM5B is the most prominent KDM under
inactive conditions (Figure 4B). To rule out unspeciﬁc
eﬀects of our cell-cycle manipulations, we checked the
binding of KDM1 and CoREST to their bona ﬁde neuro-
nal target SCG10 (16): consistent with a repressive role
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Nucleic Acids Research, 2008, Vol. 36, No. 20 6597of the complex in non-neuronal cells, both proteins were
substantially enriched in G1/S and G2/M, and inspection
of the H3K4 methylations conﬁrmed undetectable levels
of H3K4me2 and high levels of H3K4me1 (Figure 4C).
Because of the presence of H4K20me3 under inactive
conditions (Figure 3), we also examined the major enzyme
that leads to this modiﬁcation, KMT5B (SUV4-20h1,
ref. 51): it was indeed present both on Cyclin B2 and
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6598 Nucleic Acids Research, 2008, Vol. 36, No. 20PCNA under inactive conditions and maximal binding
was scored on the –2 nucleosome (Figure 4A). Finally,
we controlled polymerase II association, which indeed
peaked around the core Cyclin B2 promoter in G2/M
and, in a more widespread way, in G1/S on PCNA, cor-
relating with expression. In conclusion, components of
histone-modifying complexes are recruited with a timing
consistent with the histone PTMs shown in Figure 3, and,
surprisingly, KDMs acting on H3K4 might be involved
in the process of activation.
Inhibition ofKDM1 leads to promoter inactivation
The results shown above suggest a positive role of
KDM1 and CoREST in promoter activation; this
could be monitored by inhibiting the enzymatic activity
of KDM1 with tranylcypromine (tranylcypromine-
2-phenylcyclopropylamine) (52,53). The drug had a
modest eﬀect on S-phase progression over a wide range
of concentrations (Figure 5A, data not shown), and when
added to nocodazole, an eﬃcient G2/M arrest was
maintained (Figure 5A). We assayed the levels of gene
expression in Q-PCR and the increase of G2/M
promoters—Cyclin B1, Cyclin B2 and CDC25C—after
G2/M arrest was blocked by tranylcypromine addition;
the drug had modest eﬀects when incubated in cycling
cells. At the opposite, the repression of PCNA in G2/M
was reversed; the same was true for other G1/S genes, such
as Cyclin D1 and Rad17 (data not shown). The data were
normalized with GAPDH and the non-cell-cycle regulated
gene APOBEC3B was unaﬀected in all conditions. ChIP
assays indicated that tranylcypromine increased the
levels of H3K4me2 and dramatically decreased those
of H3K4me1 on Cyclin B2 (Figure 5C); the levels of
H3K4me3 were generally high after tranylcypromine
treatment. Recruitment of KDM1 was dramatically
decreased, while CoREST was mostly unaﬀected
(Figure 5C). In keeping with promoter repression, the
H4K20me3 was present, speciﬁcally in the core and down-
stream nucleosomes. On the active PCNA promoter,
instead, this repressive mark was generally eliminated,
the levels of H3 methylations, including H3K4me1,
high (Figure 5C). We checked by western blot, the overall
levels of H3 methylations under these conditions, and
we observed the expected increase in H3K4me2 and
decrease in H3K4me1 in cycling and G2/M-arrested cells
treated with tranylcypromine (Figure 5D). The levels of
H3K4me3 were less aﬀected. No change was observed in
the overall levels of histone H3 and of KDM1. Therefore,
the eﬀect of tranylcypromine on H3K4me2/1 levels is
conﬁrmed and the absence of KDM1 from the pro-
moters was not due to a global decrease in the protein
levels. We conclude that a tranylcypromine-inhibited
KDM1 fails to bind to promoters, and that the block
of H3K4me1-2 demethylation leads to inactivation of
Cyclin B2 in G2/M; a KDM1-independent increase of
H3K4me1 on G1/S promoters is associated with removal
of negative marks and release from repression.
We performed functional inactivation studies, inhibit-
ing both KDM1 and CoREST in HCT116 by RNAi:
compared to transfections with scrambled siRNA,
we obtained a robust decrease of KDM1 and coREST
with the respective siRNAs, as judged by western blots
of nuclear extracts (Figure 5E). Furthermore, inactivation
of CoREST had a negative eﬀect on KDM1 levels, as
detailed before (48,49). The overall levels of H3K4me1
dropped and those of H3K4me2 increased: in both
cases, the eﬀect was more pronounced upon RNAi of
KDM1 (Figure 5E). We then assayed the expression
levels of cell-cycle genes by Q-PCR at two time points—
40 and 64h post-transfections—under two conditions:
cycling and G2/M-arrested cells. Figure 5F shows that
RNAi of KDM1 and, to a lesser degree, of CoREST
decrease Cyclin B1, Cyclin B2 and CDC25C mRNA
levels both in cycling conditions, and following the
expected G2/M increase. The eﬀect was more complex
on PCNA, since the mRNA decreased after KDM1 elim-
ination under cycling conditions, but increased after
nocodazole treatment. All the data were normalized for
GAPDH expression and indeed the levels of the non cell-
cycle regulated gene APOBEC3B did not vary. These
results are largely in agreement with those of the pharma-
cological inactivation of KDM1, suggesting an active role
for KDM1-CoREST on G2/M promoters and a more
complex behavior on G1/S genes.
Roleof NF-Y inthe establishment of thehistone
methylation landscape
Because of the importance of NF-Y in the regulation of
the Cyclin B2 and PCNA promoters (54,55), a relevant
issue was to verify its role in the positioning of histone
methylations and the recruitment of the enzymatic entities
responsible for their deposition. To assay this, we used an
adenovirus containing a dominant negative mutation in
the DBD subdomain of NF-YA (YA-DN): the protein
associates with the histone fold dimer, rendering the
trimer incapable of CCAAT association (46). As a control,
we infected cells with wt Ad-NF-YA and Ad-GFP viruses.
The eﬃciency of YA-DN in aﬀecting NF-Y-dependent
transcription was controlled in RT-PCR with cell-cycle
genes (Supplementary Figure 2A): as the results with wt
NF-YA and GFP controls were similar, we pursued
further analysis only with the latter. We designed a pro-
tocol whereby HCT116 cells were ﬁrst infected with
YA-DN or GFP viruses for 8h, released from the viruses
and grown for 16h in nocodazole to obtain a block in
G2/M (Supplementary Figure 2B). We then analyzed
histone methylations with the antibodies used before.
As expected, YA-DN leads to a substantial reduction
in NF-Y binding to Cyclin B2, as measured with an
anti-YB antibody (Figure 6A). Recovery of H2B was
increased, speciﬁcally in the core promoter; H3 and H4
did not vary signiﬁcantly. The expected decrease in
H3K4me3 and H3K79me2 (39) was coupled to that of
H3K36me3, downstream of the TSS (Figure 6B). In addi-
tion, there was an increase in H4K20me3, but not of
H3K27me3. H3K4me2 remained substantially unchanged,
but a signiﬁcant drop in H3K4me1 was evident. We con-
trolled the overall levels of these PTMs in western blot
analysis of nuclear extracts derived form cells infected
with the two viruses: Supplementary Figure 2C shows
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Figure 5. KDM1 inhibition by tranylcypromine and siRNA. (A) FACS analysis of HCT116 cells untreated and treated with tranylcypromine with and
without nocodazole. (B) Q-PCR analysis of mRNA expression, in cells treated with tranylcypromine and/or nocodazole. The genes analyzed were Cyclin
B1, Cyclin B2, CDC25C (G2/M) and PCNA (G1/S). All data were normalized for GAPDH expression and the non-cell-cycle regulated APOBEC3B was
used as a further control. (C) ChIP analysis of H3/H4 methylations and of KDM1 and coREST binding along the Cyclin B2and PCNA promoters. ChIPs
were performed with the indicated antibodies on chromatin of cells arrested in G2/M, with and without tranylcypromine; black bars correspond to G2/M
cells, white ones to G2/M cells treated with tranylcypromine. The values are normalized for the amount of H3/H4 immunoprecipitated in parallel.
(D) Western blot of HCT116 nuclear extracts of untreated, tranylcypromine and G2/M-tranylcypromine-treated cells with the indicated antibodies.
(E) Western blot analysis of HCT116 cells after KDM1 and coREST siRNA interference. Protein levels were compared with equal amounts of nuclear
extracts derived from cells transfected with a control scramble siRNA. Nuclear extracts were prepared 40h after transfections of siRNAs. (F) Gene
expression analysis of cell-cycle genes after KDM1 and coREST RNA interference and nocodazole treatment, as in (E). Two diﬀerent time points were
checked in Q-PCR: 40 and 64h after transfection. All data were GAPDH normalized. APOBEC3B gene was used as a further control.
6600 Nucleic Acids Research, 2008, Vol. 36, No. 20that there are modest changes, with a small increase in
H3K4me1, ruling out that the changes observed in the
ChIP assays are due to gross, global modiﬁcations of the
methylation levels. We conclude that NF-Y removal leads
to the local elimination, or reduction, of positive marks.
The lower levels of H3K36me3 and H3K79me2 suggest a
block in elongation, while the changes in H3K4me3 and
H3K4me1 indicate that NF-Y is important for regulation
of H3K4 methylations.
We evaluated the association of histone-modifying
complexes in the same experimental setting and the
results are shown in Figure 7A: consistent with promoter
repression, and with the lower levels of H3K4me3,
KDM5A and KDM5B were eﬃciently recruited, and
Menin removed, by YA-DN. The substantial recruitment
in KMT5B on upstream nucleosomes in the NF-Y-
depleted promoter is in agreement with the of increase
of H4K20me3, albeit this was more prominent in down-
stream nucleosomes (Figure 7A). Interestingly, the pres-
ence of Pol II on the inactive Cyclin B2 promoter was
only marginally aﬀected. KDM1 association remained
substantially elevated, somewhat decreasing only in the
core promoter, while CoREST association was lost
throughout the promoter. The binding of CoREST was
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Nucleic Acids Research, 2008, Vol. 36, No. 20 6601further checked on two control promoters, SCG10 and
APOBEC3B; on the former, the YA-DN removed the
protein from the promoter, on the latter, a CCAAT-box
promoter, it did not (Figure 7B). Therefore, removal of
CoREST is not a general feature of abolishing binding of
NF-Y to CCAAT boxes. In both cases, and contrary to
what is observed on Cyclin B2, the levels of H3K4me1
were high after infection with the YA-DN.
The NF-Y-dependent association of CoREST to Cyclin
B2 suggested to ascertain whether there are interactions
between the two proteins in vivo; nuclear extracts were
immunoprecipitated with anti-YB and control antibodies,
and bound fractions assayed in western blots: a
substantial amount of CoREST, but not of KDM1, was
indeed immunoprecipitated with the anti-YB (Figure 7C),
conﬁrming a speciﬁc interaction between the two
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6602 Nucleic Acids Research, 2008, Vol. 36, No. 20endogenous proteins. Control thioredoxin was bound only
to the anti-thioredoxin antibody.
In summary, the recruitment of KDM5s and the
removal of KMT2 are consistent with the lower levels of
H3K4me3 observed in the absence of NF-Y; the lack of
CoREST is consistent with direct recruitment. Finally,
the modest reduction in Pol II, compared to the dramatic
decrease in H3K79me2 and H3K36me3, indicates a role of
NF-Y in Pol II elongation.
DISCUSSION
We developed single nucleosome ChIP assays and adapted
the system to study cell-cycle regulated promoters.
By doing so, we detailed the presence of a novel type of
nucleosome-free region under active conditions. Three
major ﬁndings are reported: (i) the presence of H3-H4
on core promoters under active conditions, with the
expected ‘positive’ post-translational modiﬁcations, is
coupled to the substitution of H2B-H2A with the his-
tone-fold containing NF-Y; (ii) methylations of H3 at
lysine 4 are highly regulated by dynamic recruitment of
KMT2 and KDM complexes; speciﬁcally, H3K4me1 is
important for promoter activity and KDM1 plays a posi-
tive role, speciﬁcally impacting on G2/M genes; and
(iii) we ﬁnd novel roles for NF-Y, in recruiting the nucleo-
some binding cofactor CoREST, H3K36me3 deposition
and Pol II elongation.
H3-H4 on corepromoters
Chromatin assembly and disassembly on regulatory
regions is likely to have an important role in transcrip-
tional regulation, since actively transcribing genes are
depleted of nucleosomes in their promoters. This con-
cept has been conﬁrmed by genome-wide analysis of
nucleosome positioning in yeast, indicating that regions
around the TSS are generally nucleosome-free and
‘open’ for TFs binding and Pol II association (40,41). In
Drosophila and humans, the same idea applies, although
nucleosome depletions are less pronounced (42–44);
mammalians might have less stable and/or precise
NFRs, and heterogenous populations of cells might have
diﬀerent NFR conﬁgurations. The complexity of the
human system is illustrated by our MNase I ChIP analy-
sis: in a growing population of cells, mapping of nucleo-
some positioning on cell-cycle genes with a reasonable
degree of precision, and detecting phase-speciﬁc NF-Y
association, was essentially impossible.
Our analysis agrees that nucleosomes are removed
in active conditions on PCNA and Cyclin B2: H2B is
absent in core areas, the levels of H3 are generally high
and the tails modiﬁed. We cannot establish whether
H3-H4 tetramers or dimers are present, but Q-PCRs
seem to suggest the former hypothesis. The role of
NF-Y in the interplay between H3-H4 and H2A-H2B is
illustrated by two results: when NF-Y is absent from
promoters, H2B levels are re-established, positioning a
nucleosome on the TSS area; NF-Y removal by YA-DN
leads to an increase in the levels of H2B, which is speciﬁc
for the core region. Based on biochemical evidence of
interactions with H3-H4, previous in vitro nucleosome
reconstitution experiments (56) and structural considera-
tions on conserved residues (29) we indeed predicted that
‘specialized’ nucleosomes that include H3-H4 and NF-Y
are present in vivo. H3-H4 tetramers actually helped
recruitment of NF-Y during nucleosome reconstitution
in vitro, under biochemical conditions in which binding
of the trimer to DNA was impossible (56). Interestingly,
genomic studies on nucleosome positioning in yeast found
the yeast equivalent HAP2/3/5 on top of the list of TFs
whose sites are highly biased with respect to nucleosome
positioning, predicting that CCAAT would be left open
for binding by precise nucleosome locations on core
promoters (57).
Our data might also have implications on the interpre-
tation of recent genome-wide studies of nucleosomes in
the human system: by using anti-H3 antibodies, the eﬀec-
tive presence of nucleosomes might have been overrated,
as we imagine that many promoters might be in the
conditions described here: the dip in core promoter areas
observed in these studies is predicted to be deeper with
H2A-H2B antibodies. This might be particularly true for
promoters containing multiple CCAAT boxes, such as the
vast majority of those active speciﬁcally in G2/M, because
their precise alignements are a conserved and widespread
feature (54, Dolﬁni,D. and Mantovani,R., submitted).
A speciﬁc role for H3-H4 in activation of yeast promo-
ters has been postulated based on the well-characterized
PHO5 system (58, reviewed in ref. 59). In particular,
nucleosome disassembly is essential for induction, and
tetramers are observed under pre-induction conditions; a
key chaperone factor—Asf1—binds to H3–H4 dimers to
disassemble them from the center of the nucleosome: in
order to do that, the DNA needs to be partially unwound
and H2A-H2B must be removed. H2A-H2B assembly is
also a regulated process. We propose a scenario whereby
NF-Y plays the role of a ‘deviant’, sequence-speciﬁc
H2A-H2B-like that interferes with nucleosome reconsti-
tution and promoter inactivation, making chromatin
locally accessible for histone-modifying machines. It is
conceivable that other H2A-H2B-like complexes with
some sequence preference, such as the TAFs of the
TFIID complex (25,26) and NC2/Dr1-Drap1 (24), could
have the similar role.
Regulation of H3K4methylations
One of the most intriguing questions concerning
the histone PTMs is how they are locally regulated.
Genome-wide analysis has clariﬁed that certain histone
modiﬁcations are associated with ‘active’ or ‘inactive’
chromatin and that islands exists with mixed positive
and negative marks (13,14). A relevant question is what
brings complexes to speciﬁc locations in a given cellular
context. It seems reasonable to postulate that TFs have
a part in deciding this issue, and there are examples of
TFs that recruit machines that impact on the histone
PTMs (60). Recently, for example, we found that certain
H3 methylations require prior NF-Y binding. The data
presented here extend the importance of NF-Y to
H3K36me3, a mark produced by KMT3 and associated
Nucleic Acids Research, 2008, Vol. 36, No. 20 6603with transcriptional elongation (61–64); interestingly,
elimination of NF-Y leads to a decrease, not abolition
of Pol II recruitment; gene inactivation, therefore, is
most likely caused by lack of this step. It should be
noted that in the context of genes inducible by ER
stress, NF-Y is apparently involved in Pol II recruitment
and has a more ‘resident’ role (65,66).
Our data also represent a somewhat unexpected twist
for H3K4 methylations. H3K4me1 and H3K4me3 corre-
late with expression, and H3K4me2 is high—and in fact
generally higher—under cell-cycle conditions in which the
speciﬁc promoter is inactive (Figure 8). This dynamic
behavior is accomplished by increasing H3K4me3 through
recruitment of KMT2, and demethylation through the
activity of KDM1 and, possibly, KDM5A. Interestingly,
tranylcypromine decreases the global levels of H3K4me1
and increases those of H3K4me2, as expected, but it does
not decrease the levels of H3K4me3, suggesting that
KDMs that act on this modiﬁcation cannot compensate
for the block on KDM1. ChIP–chip analysis of ENCODE
arrays indicates that H3K4me1 is a signature of human
enhancers, while H3K4me3 are found mostly on promot-
ers (11). It should be noted that enhancers are known to
be entry sites for Pol II, and higher levels of Pol II, TAF1
and p300 were indeed observed in these regions; there is
also growing evidence that enhancers generate RNA Pol II
transcripts (67,68). In a genome-wide ChIP-Seq screening,
Barski et al. (13) found H3K4me1 on active promoters,
with a distribution less focused on the TSS, with respect to
H3K4me3. Thus, the presence of H3K4me1 might not
be so restricted to enhancers and the distinction with pro-
moters might be subtle. Finally, positional clues in our
analysis are generally in agreement with previous studies:
in particular, high levels of H3K79me2 and H3K36me3 on
nucleosomes downstream of TSS in active conditions,
and H4K20me3 on inactive ones.
It was important to analyze the association and activ-
ities of enzymes that methylate and demethylate H3K4.
As for the formers, ChIP analysis of Menin, part of the
KMT2 complexes, found it predominantly in active con-
ditions, in accordance with the idea that these complexes
are involved in mono- and trimethylation. The latter mod-
iﬁcation would require additional proteins, such as ASH2
(47), not analyzed here. We conﬁrmed the requirement of
NF-Y for KTM2 recruitment (39) and it is therefore not
surprising that H3K4me1 is also aﬀected. Association
of KTM2 was maximal away form the core region,
suggesting that the complex either travels, or modiﬁes
nucleosomes neighboring its location. Two H3K4me3
demethylases were analyzed, KDM5A and KDM5B; the
former was widespread on PCNA and Cyclin B2 in active
conditions. The enzyme is able to demethylate H3K4me2
as well, possibly contributing to demethylation of H3K4.
In summary, KDM1 and KDM5A indirectly impact on
H3K4me1 by providing a substrate for KTM2 activity
and balancing its drive toward H3K4me3. KDM5B,
instead, is more constant throughout the cell cycle and
the most prominent KDM under inactive conditions.
This implies that the enzymatic activity is ineﬃcient
during the active phase. Interestingly, overexpression of
KDM5B leads to a strong G2/M arrest, likely due to
inactivation of genes involved in progression through
mitosis (67). Most G2/M genes contain one, and often
multiple CCAAT boxes (35) and indeed NF-Y inactiva-
tion leads to depletion of G2/M populations, due to gene
inactivation (36,37). In keeping with this, NF-Y removal
led to KDM5B—and KDM5A—recruitment and
H3K4me3 demethylation. It seems reasonable to postulate
that KDM5B targets G2/M promoters speciﬁcally orga-
nized by NF-Y. An additional interesting point pertains
to the mechanisms of recruitment of KDM5s, which
might be direct. In fact, they contain an ARID
sequence-speciﬁc DNA-binding domain which recognizes
GC-rich sequences: although the precise sequences derived
by in vitro analysis (69,70) are absent from the PCNA and
Cyclin B2 promoters, it is possible that the two proteins
recognize variations of the theme, perhaps with the help
of interacting factors.
Figure 8. Model of regulation of H3K4 methylations.
6604 Nucleic Acids Research, 2008, Vol. 36, No. 20A relevant ﬁnding of our study is the behavior of
KDM1, an enzyme that eﬃciently targets H3K4me2/1,
and is involved in repression of developmentally regulated
genes (16,71,72). In many cases, the duo takes part in
repression programs and CoREST is biochemically asso-
ciated with HDACs (73,74). We conﬁrm that both
proteins are associated to a repressed neuronal promoter,
but it is clear that they have a diﬀerent role on cell-cycle
promoters, particularly of G2/M: speciﬁc inhibition by
tranylcypromine and RNAi inactivation leads to lack of
KDM1 recruitment, a global as well as a local decrease
in H3K4me1, an increase in H3K4me2 and lack of trans-
criptional induction.
Precedents for an activating role of KDM1 have been
reported. The demethylase is a positive as well as a nega-
tive regulator of pituitary-speciﬁc gene expression during
development, speciﬁcally of the Gh gene (71); several
reports linked it to inducible transcription mediated
by nuclear receptors, AR and ER (75–77). Importantly,
in a genome-wide location screening, the majority of
KDM1
þ promoters were bound by Pol II and expressed
(78). Finally, KDM1 binds to the the cell-cycle regulated
viral gene Cp, possibly through E2F–Rb interactions, and
functional inactivation leads to repression (79). It was
postulated that the positive activity of KDM1 is exerted
through demethylation of H3K9me2. The direct protein–
protein interaction between NF-Y and CoREST, but not
KDM1, suggests that NF-Y is responsible for CoREST
recruitment. Without NF-Y, an increase in KDM1 asso-
ciation to Cyclin B2 is matched by a CoREST—and
H3K4me1–decrease, conﬁrming that the two partners
need to be present for full enzymatic activity (16,46).
As one has a histone-like structure and the other—
CoREST—interacts with DNA in a nucleosomal context
(80), it will be interesting to pinpoint the domains respon-
sible for NF-Y–CoREST interactions. The model we pro-
pose is illustrated in Supplementary Figure 4, whereby the
NF-Y–CoREST–KDM1 ‘trio’ is essential for full induc-
tion of G2/M genes by maintaining high levels of the key
H3K4me1, balancing the drive toward H3K4me3, a mod-
iﬁcation that does not guarantee activation.
Finally, the activating ‘trio’ work in a context-
dependent way and have opposite functional outcomes
in developmentally regulated units. KDM1 was shown
to associate with DNA-binding, repressive TFs, such as
TFII-I, ZEB1/2 and ZNF217 (81–83). In this respect,
NF-Y is also found on several repressed genes, mainly
of the GO Development and Diﬀerentiation category,
and its removal leads to gene activation (38): therefore,
the interactions noticed here should also be investigated
by genetic means on this large class of genes.
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